People · Operator
Named in public records as an officer, director or promoter · active 2010–2012 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Stemgent, Inc. | — | Biotechnology | Series A | $37.9M | $408.5M | 2010 |
Augustine R. Lawlor at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Augustine R. Lawlor on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Augustine Lawlor | 1 | 8 |
| Ian Ratcliffe | 1 | 6 |
| Ralph E. Christoffersen | 1 | 6 |
| Augustine E. Lawlor | 1 | 6 |
| Ralph Christoffersen | 1 | 5 |
| Harold R. Werner | 1 | 4 |
| Harold Werner | 1 | 2 |
| Ian E. Ratcliffe | 1 | 1 |
| Stefan E. Miltenyi | 1 | 1 |
| Stefan R. Miltenyi | 1 | 1 |
| Ralph R. Christoffersen | 1 | 1 |
| Stefan Miltenyi | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.